New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
Manufacturing Agreement Advances Metformin Ophthalmology Platform Toward First-in-Human Clinical StudyPalm Beach Gardens, FL, April 15, 2026 ...
Talking With Docs on MSN
Macular degeneration: the leading cause of blindness in the developed world
Macular degeneration: the leading cause of blindness in the developed world ...
Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips.
I’m an ophthalmologist, a physician who specializes in medical and surgical eye care, and I’m hoping you can help me debunk a ...
A new study reveals an unexpected mechanism behind how humans develop sharp, color-rich vision before birth, pointing to a coordinated role between key biochemical signals in the retina.
Trends in the rates of glaucoma, cataract and age-related macular degeneration around the world point to a “complex interplay ...
The FDA approved an extension of dosing intervals for Eylea HD in patients with diabetic macular edema and wet age-related ...
Copyright: © 2026 The Author(s). Published by Elsevier Ltd. Anti-VEGF therapy is the primary treatment for nAMD, a leading cause of blindness among older individuals ...
AMD is a common cause of blindness in high-income countries. It has previously been established that treatment has a high patient and financial burden, with limited long-term success. Prior analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results